Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma

Liqing Zhuang; C Soon Lee; Richard A Scolyer; Stanley W. McCarthy; Xu Dong Zhang; John F. Thompson; Peter Hersey

doi:10.1038/modpathol.3800750

Back

Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma

Article 2007 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2006

Increased expression of Mcl-1 and Bcl-XL and decreased expression of Bcl-2 associated with melanoma progression and transcription factors

L. Zhuang, C. Lee, Richard A Scolyer, Susan McCarthy, X. Zhang, James A. Thompson, Peter Hersey

Article2009

Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins

Liqing Zhuang, Richard A Scolyer, Rajmohan Murali, Stanley W. McCarthy, Xu Dong Zhang, John F. Thompson, Peter Hersey

Article2015

Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma

James S. Wilmott, Andrew J. Colebatch, Hojabr Kakavand, Ping Shang, Matteo S. Carlino, John F. Thompson, Georgina V. Long, Richard A Scolyer, Peter Hersey

Article2017

Lower levels of interleukin‐1<i>β</i> gene expression are associated with impaired Langerhans’ cell migration in aged human skin

Suzanne M. Pilkington, Stephanie Ogden, L.H. Eaton, Rebecca J. Dearman, Ian Kimber, Christopher Em Griffiths

Article2004

Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma

de Aguirre, Patricia Boya, Daniel Bellet, Sandrine Faivre, Frédéric Troalen, Jean Bénard, Patrick Saulnier, Sally Hopkins-Donaldson, Uwe Zangemeister‐Wittke, Guido Guido Kroemer, Éric Raymond